Dr. Yajnavalka Banerjee is a Biochemist trained at The Scripps Research Institute, USA and the Max-Planck Institute for Biophysical Chemistry, Germany. He is currently, an Associate Professor of Biochemistry and with clinical research, is involved in teaching medical students, curriculum and course-design, delineation of student assessment policies and health-profession education. He has numerous academic grants as well as funding from leading pharmaceutical companies such as Pfizer and Amgen. His research focuses on dyslipidemia and associated disorders. Till date, YB has 51 peer-reviewed indexed publications and two patents; and is on the editorial board of numerous biomedical science and medicine journals.